Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
M. P. Celis, M. A. Spruit, J. D. Does, R. Mostert, T. Möller, N. Uszko-Lencer, H. J. Pennings, P. P. Janssen, E. F. M. Wouters (Maastricht, Horn, Netherlands). Pharmacological treatment of self-reported cardiovascular comorbidity in COPD patients. Eur Respir J 2007; 30: Suppl. 51, 2679

Member's Comments

No comment yet.

Related content which might interest you: Prevalence of comorbidities in patients with COPD in south-Spain Source: Annual Congress 2011 - Respiratory epidemiology: comorbidity Year: 2011 Cardiovascular comorbidity in severe COPD patients Source: International Congress 2017 – Markers of COPD progression Year: 2017 Prevalence of comorbidity in patients with COPD and its effect on mortality Source: Annual Congress 2003 - Staging and outcome in COPD Year: 2003 Impact of cardiovascular comorbidities on COPD exacerbations Source: Annual Congress 2007 - COPD and comorbidity Year: 2007 Disease-specific medication, patient-reported diagnoses and their relation to COPD severity for common comorbidities in COPD Source: International Congress 2017 – Extrapulmonary comorbidities in COPD Year: 2017 Relationship between pharmacotherapy and severity of disease in patients with COPD Source: Eur Respir J 2007; 30: Suppl. 51, 73s Year: 2007 Impact of co-morbidities on the rehabilitation outcome in COPD patients Source: Annual Congress 2007 - Impact of comorbidities in pulmonary rehabilitation Year: 2007 Body composition in COPD patients with self-reported cardiovascular comorbidity Source: Eur Respir J 2007; 30: Suppl. 51, 452s Year: 2007 Efficacy of roflumilast with concomitant cardiovascular medication in patients with COPD Source: Annual Congress 2013 –Novel mechanisms for established drugs for asthma and COPD management Year: 2013 Hospitalisation of COPD patients due to comorbidity Source: Annual Congress 2008 - Comorbidities in COPD Year: 2008 Management of patients with asthma or COPD and cardiovascular disease: risks versus benefits Source: Eur Respir Monogr 2020; 88: 66-81 Year: 2020 Impact of hyperglycaemia and comorbid diabetes mellitus on short and long-term outcome after COPD exacerbation Source: Annual Congress 2013 –Monitoring respiratory diseases: role of comorbidities and lung involvement Year: 2013 The impact of comorbidities on the short-term serious health outcomes in hospitalized COPD patients due to exacerbation Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Clinical effectiveness of antidepressive drug in patients with COPD and concomitant moderate depressive episode Source: Annual Congress 2013 –COPD treatment and others Year: 2013 Quantify comorbidities burden of chronic obstructive pulmonary disease patients using medication regimen complexity index Source: International Congress 2016 – Novel avenues in the treatment of COPD I Year: 2016 Do cardiovascular drugs reduce mortality in patients with COPD in daily practice? A study in primary care Source: Annual Congress 2007 - Management of COPD: pushing forward the boundaries in primary care Year: 2007 Prevalence and risk factors of depression in patients with COPD Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009 Exacerbation types by COPD severity; risk of hospitalisation by patients not seeking treatment Source: Eur Respir J 2003; 22: Suppl. 45, 353s Year: 2003 Prevalence and risk factors of co-morbidities in subjects with mild and moderate COPD detected by screening Source: Annual Congress 2013 –The best abstracts in extra-pulmonary features and pulmonary rehabilitation Year: 2013 The effects of anxiety and depression on treatment adherence in COPD patients Source: Annual Congress 2010 - COPD: systemic inflammation and comorbidities Year: 2010